Patents by Inventor Yu Ping Maguire

Yu Ping Maguire has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Uses of Lp-PLA2 in combination to assess coronary risk
    Publication number: 20110070223
    Abstract: This invention relates to a method for assessing risk of Coronary Vascular Disease (CVD). Specifically, it relates to utilizing risk assessment from both Lipoprotein Associated Phospholipase A2 (Lp-PLA2) and C-reactive protein (CRP) in combination. In addition the invention relates to a method for assessing risk of Coronary Vascular Disease (CVD) in a patient with low to normal Low Density Lipoprotein Cholesterol (LDL) levels utilizing both LDL and Lipoprotein Associated Phospholipase A2 (Lp-PLA2). Moreover, the invention relates to the use of risk associated with Lp-PLA2, CRP and LDL in combination and specific ranges thereof to predict Coronary Vascular Disease.
    Type: Application
    Filed: November 24, 2010
    Publication date: March 24, 2011
    Applicant: diaDexus, Inc.
    Inventors: Robert L. Wolfert, Yu Ping Maguire, Yu Ping Li, Mark Joseph Sarno
  • ORAL CANCER MARKERS AND THEIR DETECTION
    Publication number: 20090023138
    Abstract: Methods of detecting progression from precancer to cancer are provided utilizing toluidine blue staining as well as detecting allelic variation at microsatellite loci. An allelic variation in one or more locus is indicative of a progression from precancer to cancer.
    Type: Application
    Filed: July 17, 2007
    Publication date: January 22, 2009
    Applicant: ZILA BIOTECHNOLOGY, INC.
    Inventors: Douglas D. Burkett, David Sidransky, Antonette C.P. Allen, Francis A. Chiafari, Mark Bride, Yu Ping Maguire